FDA Notices of Judgment Collection, 1908-1966

4183. Misbranding of dextro-amphetamine sulfate tablets and pentobarbital sodium capsules. U. S. v. Paul B. Ginther (Central Drug Co.). Plea of guilty. Fine of $625, plus costs.